Lyell Immunopharma, Inc. Quarterly Operating Lease, Liability, Noncurrent in USD from Q4 2020 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Lyell Immunopharma, Inc. quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q4 2020 to Q2 2025.
  • Lyell Immunopharma, Inc. Operating Lease, Liability, Noncurrent for the quarter ending June 30, 2025 was $46.6M, a 12.6% decline year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $46.6M -$6.73M -12.6% Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $48.9M -$6.31M -11.4% Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $51M -$5.9M -10.4% Dec 31, 2024 10-Q 2025-08-12
Q3 2024 $51.4M -$7.14M -12.2% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $53.3M -$6.9M -11.5% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $55.2M -$6.67M -10.8% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $56.9M -$6.27M -9.93% Dec 31, 2023 10-K 2025-03-11
Q3 2023 $58.6M -$6.06M -9.38% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $60.2M -$5.85M -8.86% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $61.8M -$5.65M -8.37% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $63.2M -$3.48M -5.22% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $64.6M -$1.05M -1.6% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $66.1M +$4.6M +7.49% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $67.5M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $66.7M +$15.7M +30.8% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $65.7M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $61.5M Jun 30, 2021 10-Q 2021-08-12
Q4 2020 $51M Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.